Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.37%)
At close: Sep 4, 2026 · 4:00 PM EDT

Compugen (CGEN) Net Margin Growth (3y) (2012 - 2018)

Analysis

Compugen (CGEN) Net Margin Growth (3y) (2012 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -374.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -44.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 6,620.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -13,815.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 7,793.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 9,934.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -5,319.00
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 31,387.00
10 Compugen 242.44 Mn 156.82 Mn -92,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 290,422.00
Mar 31, 2018 123,340.00
Dec 31, 2016 -1.58 Mn
Sep 30, 2016 -1.08 Mn
Jun 30, 2016 1.25 Mn
Mar 31, 2016 -709,180.00
Dec 31, 2015 400,402.00
Sep 30, 2015 30,590.00
Dec 31, 2013 110,399.00
Jun 30, 2013 -1.37 Mn
Mar 31, 2013 -27,251.00
Dec 31, 2012 380,230.00
Sep 30, 2012 -514,167.00